ELabsEurope admits need for bricks and mortar:
This article was originally published in Clinica
ELabsEurope is looking to buy a traditional laboratory distribution business to augment its revenue. The European online distributor is looking to spend up to $10 million of its $20 million cash reserves. The market for online business-to-business trading in clinical supplies has yet to take off and last year pioneer company Ventro announced that it was closing its Promedix medical distribution site.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.